Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long

Posted on May 31, 2026
By Washington Post
0 Views
1 min read

‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long

The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal disease.